Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28746 | 1.00 | MAPT (1.00) | MAPTGAAPOLBAKR1C3CA1 | |
| SCHEMBL7612003 | 0.98 | MAPT (0.96) | MAPTGAAPOLBAKR1C3CA1 | |
| SCHEMBL7612010 | 0.98 | MAPT (0.96) | MAPTGAAPOLBAKR1C3CA1 | |
| Benzophenone SCHEMBL15661696 | 0.98 | MAPT (0.96) | MAPTGAAPOLBAKR1C3CA1 | |
| SCHEMBL31333067 | 0.98 | MAPT (0.96) | MAPTGAAPOLBAKR1C3CA1 | |
| Nitrogen SCHEMBL28332724 | 0.96 | MAPT (0.92) | MAPTGAAPOLBAKR1C3CA1 | |
| Biphenyl SCHEMBL28042001 | 0.94 | MAPT (0.88) | MAPTGAAPOLBAKR1C3CA1 | |
| Acetic Acid SCHEMBL6211199 | 0.94 | MAPT (0.88) | MAPTGAAPOLBAKR1C3CA1 | |
| SCHEMBL8374908 | 0.93 | MAPT (0.87) | MAPTGAAPOLBAKR1C3CA1 | |
| Trimethylammonium SCHEMBL27837120 | 0.92 | MAPT (0.85) | MAPTGAAPOLBAKR1C3CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118598854-A | Small molecular compound with high HPPD (high-pressure sensitive PD) inhibitory activity and synthesis method thereof | 上海冰鉴信息科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| EP-4370498-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | Biocoat, Incorporated (US) | 2024-05-22 | — | — | EP | claimed |
| WO-2023287638-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | BIOCOAT, INCORPORATED (US) | 2023-01-19 | — | — | WO | claimed |
| WO-2026086794-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2026-04-30 | — | — | WO | disclosed |
| CN-115209883-B | Novel cell metabolism regulating compound and use thereof | 新月生物科学 | 2025-05-20 | — | — | CN | disclosed |
| EP-4529621-A1 | UV/HEVL-FILTERING CONTACT LENSES | Alcon Inc. (CH) | 2025-04-02 | — | — | EP | disclosed |
| US-20250099407-A1 | 2-AMINO BENZOPHENONE DERIVATIVES FOR TARGETED FERROPTOSIS INDUCTION IN CANCER THERAPY | INDIAN INSTITUTE OF TECHNOLOGY KANPUR (IN) | 2025-03-27 | — | — | US | disclosed |
| US-20250099407-A1 | 2-AMINO BENZOPHENONE DERIVATIVES FOR TARGETED FERROPTOSIS INDUCTION IN CANCER THERAPY | INDIAN INSTITUTE OF TECHNOLOGY KANPUR (IN) | 2025-03-27 | — | — | US | disclosed |
| CN-119322428-A | Preparation method of photosensitive nano-particles, photoresist solution and two-photon pattern | 甬江实验室 | 2025-01-17 | — | — | CN | disclosed |
| CN-119072467-A | Novel diazapine compounds targeting yellow fever virus non-structural 4B (NS 4B) protein and methods of use thereof | 巴鲁克斯布伦博格研究所 | 2024-12-03 | — | — | CN | disclosed |
| CN-118598854-A | Small molecular compound with high HPPD (high-pressure sensitive PD) inhibitory activity and synthesis method thereof | 上海冰鉴信息科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-113501764-B | Asymmetric synthesis method of trifluoromethyl-containing polyfunctional cyclopentenone derivative | 重庆大学 | 2023-05-23 | — | — | CN | disclosed |
| CN-113501766-B | Asymmetric synthesis method of multi-functional cyclopentenone derivative containing difluoroalkyl | 重庆大学 | 2023-05-23 | — | — | CN | disclosed |
| EP-4093384-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | Crescenta Biosciences (US) | 2022-11-30 | — | — | EP | disclosed |
| CN-115209883-A | Novel cell metabolism-regulating compounds and uses thereof | 新月生物科学 | 2022-10-18 | — | — | CN | disclosed |
| CN-114736131-A | Synthetic method of bromfenac sodium | 郑州灏瑞医药科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-11359123-B2 | Compositions containing difluoromethane, tetrafluoropropene, and carbon dioxide and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2022-06-14 | — | — | US | disclosed |
| WO-2022102407-A1 | PHOSPHOR | 住友化学株式会社 | 2022-05-19 | — | — | WO | disclosed |
| WO-2022102409-A1 | PHOSPHOR | 住友化学株式会社 | 2022-05-19 | — | — | WO | disclosed |
| WO-2022102408-A1 | PHOSPHOR | 住友化学株式会社 | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099407-A1 | 2-AMINO BENZOPHENONE DERIVATIVES FOR TARGETED FERROPTOSIS INDUCTION IN CANCER THERAPY | AIFM2, BAD, MCL1 | MAPT 3272/4885GAA 2983/4885POLB 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.